Evolent Health Shares Drop on $350 Million Note Offering
By Dean Seal
Shares of Evolent Health fell after the company said it would offer $350 million in convertible notes.
The stock retreated 15% to $25.08 in early trading. Shares are down 11% year-to-date.
The healthcare company said Tuesday morning that it plans to offer $350 million in convertible senior notes, due in 2029, to qualified institutional investors. Initial purchasers will be given the option to buy up to an additional $52.5 million in notes.
Proceeds from the offering will be used to prepay a portion of outstanding borrowings and pay related fees under its loan facility.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
December 05, 2023 10:15 ET (15:15 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations